HomeCase StudiesBionical Emas Regulatory Affairs: Mutual Recognition Submission...

Bionical Emas Regulatory Affairs: Mutual Recognition Submission Strategy.

  • Published 12/11/2019
  • Author Danny NasmythMiller - EVP, Clinical Development
  • Division Clinical Development


Our client has a portfolio of generic ophthalmic products with EU national licences. Keen to expand their commercial footprint in Europe, they wish to file additional Marketing Authorisations, and approached Bionical Emas to help with their Submission Strategy, MAH activities and become the single EU Regulatory Point of Contact.


  • Submission Strategy & Brexit: Considered the most appropriate EU community procedure to undertake (MRP) and supported the client’s application for Requesting MRP. Outlined a customised approach to mitigate the potential impact of Brexit, for their UK filing strategy.
  • Submission documentation: Reviewing packaging, updating summary of product characteristics (SPCs) and patient information leaflets (PILs). Written a number of submission documentation, such as; clinical expert overviews and a quality overall summary. Liaising with the client’s centralised regulatory team
  • Delegation of MAH services: Our client requested a service provider who would be prepared to receive delegated services for an MAH for several members states, including the UK, reinforcing the prime request to become a single EU Regulatory Point of Contact.


  • Provided regulatory operational expertise in several EU markets, comprehensive delegation of MAH responsibilities in UK and EU
  • Expertise and support in providing Submission documentation
  • Clear strategy which continues to provide a consultative service, on an ad-hoc basis
  • A collaborative approach in which there is a common objective… supporting our client’s commercial portfolio in Europe
We can support you with…

Regulatory & Health Economic Science

We know how to overcome hurdles for routine or complex and unusual therapies in all key regions and in unfamiliar countries. Our Regulatory Team is responsible for numerous successful submissions to major competent authorities and regulatory agencies. Our skilled teams develop high-quality written documents that are compliant with global and national regulatory requirements.


How can we support you?

Our dedicated teams of experts are on hand to help should you require any additional resource or further information about our services.

COVID-19 Guidance & Measures

A statement from the Bionical Emas Group on guidance & measures regarding COVID-19 - read here

In relation to staff and visitor safety, we have full risk assessments in place for all of our workplaces. These risk assessments are revisited and updated regularly, to reflect changing risks, knowledge and circumstances, and to reflect evolving Government guidance. We have not placed the risk assessments here on the website as they would become out of date too quickly. However, you are welcome to email info@bionical-emas.com to request access to our most up to date risk assessments applicable to your needs. Please note that all our staff are notified of all applicable risk assessments and updates, along with ‘quick guides’ automatically via our e-learning system.